DTC Perspectives Magazine's Industry Forum asked some key thought leaders, including Heartbeat's Bill Drummy, about the FDA's Office of Prescription Drug Promotion (OPDP) and what they'd like to see...

Is the FDA's snail-like response to the changing marketing landscape merely annoying, or is it worse than that? Heartbeat CEO Bill Drummy believes that the FDA's refusal to provide meaningful,...

"Eighteen months ago, 80 of my closest friends and I presented before the US Food and Drug Administration on how the agency should regulate the promotion of medical products via the internet and...

This past winter I was invited to be a panelist at the DTC Perspectives Digital Conference. The topic seemed benign enough — how should healthcare marketers use digital to appropriately...

"Bill Drummy, one of the multitude of thought leaders to speak at the US Food and Drug Administration hearing on using the internet and social media to promote medical products, gives his take on the ...

The U.S. Food and Drug Administration will hold a two-day public hearing in November on how pharmaceutical companies use the web and social-media tools to market their products, the first step in a...